Pentazocine Misuse among Sickle Cell Disease Patients and The Role of Lack of Enforcement of Opioid Dispensing Regulations by Community Pharmacies: A Descriptive Observational Study

Introduction. Sickle cell disease (SCD) is a chronic disease characterized by debilitating bone pains which commonly necessitate the use of analgesic drugs including opioids and psychotropic substances such as pentazocine which are controlled medicines in Nigeria. Opioid misuse including dependence...

Full description

Saved in:
Bibliographic Details
Main Authors: Oluomachi Charity Nnachi, Chinedu Obasi Akpa, Favour Ogonna Nwani, Oghenevwogaga Obukohwo Edenya
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Advances in Public Health
Online Access:http://dx.doi.org/10.1155/2022/3877882
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568448043974656
author Oluomachi Charity Nnachi
Chinedu Obasi Akpa
Favour Ogonna Nwani
Oghenevwogaga Obukohwo Edenya
author_facet Oluomachi Charity Nnachi
Chinedu Obasi Akpa
Favour Ogonna Nwani
Oghenevwogaga Obukohwo Edenya
author_sort Oluomachi Charity Nnachi
collection DOAJ
description Introduction. Sickle cell disease (SCD) is a chronic disease characterized by debilitating bone pains which commonly necessitate the use of analgesic drugs including opioids and psychotropic substances such as pentazocine which are controlled medicines in Nigeria. Opioid misuse including dependence and addiction is an increasing trend among SCD patients, and it has serious adverse implications on their social, economic, and physical well-being. The role of lack of implementation of existent regulation on the dispensing of opioids by pharmacies has not been adequately investigated. Objective. The primary objective of this study is to define the sociodemographic and clinical implications of pentazocine misuse among patients with SCD and to describe the contributions of lack of enforcement of opioid dispensing regulations to this menace. Materials and Methods. The study was a descriptive observational study. A 29-item pretested and prevalidated questionnaire was administered to 21 SCD patients with an established history of pentazocine misuse and addiction to establish their demographics, details of opioid use, and their clinical effects. Nine community pharmacies were interviewed to ascertain their knowledge of controlled medicines and their compliance to existent regulations on the dispensation of opioids. Results. The median (interquartile range) age of the SCD subjects was 24 years. The majority of subjects (14, 66.7%) had tertiary education. Fifteen (71.4%) of them had a history of pentazocine misuse for over two years. All subjects source pentazocine injection from local pharmacies and patent medicine shops without prescription, while 19.0% get home deliveries. Seventeen (80.9%) of the SCD subjects desired to discontinue the habit; however, inadequate medical support was reported to contribute to their inability to overcome this practice in 14 (54.3%) patients. Most of the local pharmacies/drug shop proprietors are aware of drug laws guiding controlled medicines in Nigeria. However, about 77.9% of pharmacies interviewed retail pentazocine without prescription. A lack of enforcement by the state and federal taskforce was reported to contribute to this practice. Conclusion. Pentazocine misuse is a serious problem in patients with SCD. Inadequate medical support and lack of enforcement of regulations on dispensing opioids by community pharmacies are contributors to this menace.
format Article
id doaj-art-9ead1b8fac4847b9bd4e119626771e72
institution Kabale University
issn 2314-7784
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Advances in Public Health
spelling doaj-art-9ead1b8fac4847b9bd4e119626771e722025-02-03T00:59:06ZengWileyAdvances in Public Health2314-77842022-01-01202210.1155/2022/3877882Pentazocine Misuse among Sickle Cell Disease Patients and The Role of Lack of Enforcement of Opioid Dispensing Regulations by Community Pharmacies: A Descriptive Observational StudyOluomachi Charity Nnachi0Chinedu Obasi Akpa1Favour Ogonna Nwani2Oghenevwogaga Obukohwo Edenya3Department of HaematologyDepartment of HaematologyDepartment of HaematologyDepartment of Chemical PathologyIntroduction. Sickle cell disease (SCD) is a chronic disease characterized by debilitating bone pains which commonly necessitate the use of analgesic drugs including opioids and psychotropic substances such as pentazocine which are controlled medicines in Nigeria. Opioid misuse including dependence and addiction is an increasing trend among SCD patients, and it has serious adverse implications on their social, economic, and physical well-being. The role of lack of implementation of existent regulation on the dispensing of opioids by pharmacies has not been adequately investigated. Objective. The primary objective of this study is to define the sociodemographic and clinical implications of pentazocine misuse among patients with SCD and to describe the contributions of lack of enforcement of opioid dispensing regulations to this menace. Materials and Methods. The study was a descriptive observational study. A 29-item pretested and prevalidated questionnaire was administered to 21 SCD patients with an established history of pentazocine misuse and addiction to establish their demographics, details of opioid use, and their clinical effects. Nine community pharmacies were interviewed to ascertain their knowledge of controlled medicines and their compliance to existent regulations on the dispensation of opioids. Results. The median (interquartile range) age of the SCD subjects was 24 years. The majority of subjects (14, 66.7%) had tertiary education. Fifteen (71.4%) of them had a history of pentazocine misuse for over two years. All subjects source pentazocine injection from local pharmacies and patent medicine shops without prescription, while 19.0% get home deliveries. Seventeen (80.9%) of the SCD subjects desired to discontinue the habit; however, inadequate medical support was reported to contribute to their inability to overcome this practice in 14 (54.3%) patients. Most of the local pharmacies/drug shop proprietors are aware of drug laws guiding controlled medicines in Nigeria. However, about 77.9% of pharmacies interviewed retail pentazocine without prescription. A lack of enforcement by the state and federal taskforce was reported to contribute to this practice. Conclusion. Pentazocine misuse is a serious problem in patients with SCD. Inadequate medical support and lack of enforcement of regulations on dispensing opioids by community pharmacies are contributors to this menace.http://dx.doi.org/10.1155/2022/3877882
spellingShingle Oluomachi Charity Nnachi
Chinedu Obasi Akpa
Favour Ogonna Nwani
Oghenevwogaga Obukohwo Edenya
Pentazocine Misuse among Sickle Cell Disease Patients and The Role of Lack of Enforcement of Opioid Dispensing Regulations by Community Pharmacies: A Descriptive Observational Study
Advances in Public Health
title Pentazocine Misuse among Sickle Cell Disease Patients and The Role of Lack of Enforcement of Opioid Dispensing Regulations by Community Pharmacies: A Descriptive Observational Study
title_full Pentazocine Misuse among Sickle Cell Disease Patients and The Role of Lack of Enforcement of Opioid Dispensing Regulations by Community Pharmacies: A Descriptive Observational Study
title_fullStr Pentazocine Misuse among Sickle Cell Disease Patients and The Role of Lack of Enforcement of Opioid Dispensing Regulations by Community Pharmacies: A Descriptive Observational Study
title_full_unstemmed Pentazocine Misuse among Sickle Cell Disease Patients and The Role of Lack of Enforcement of Opioid Dispensing Regulations by Community Pharmacies: A Descriptive Observational Study
title_short Pentazocine Misuse among Sickle Cell Disease Patients and The Role of Lack of Enforcement of Opioid Dispensing Regulations by Community Pharmacies: A Descriptive Observational Study
title_sort pentazocine misuse among sickle cell disease patients and the role of lack of enforcement of opioid dispensing regulations by community pharmacies a descriptive observational study
url http://dx.doi.org/10.1155/2022/3877882
work_keys_str_mv AT oluomachicharitynnachi pentazocinemisuseamongsicklecelldiseasepatientsandtheroleoflackofenforcementofopioiddispensingregulationsbycommunitypharmaciesadescriptiveobservationalstudy
AT chineduobasiakpa pentazocinemisuseamongsicklecelldiseasepatientsandtheroleoflackofenforcementofopioiddispensingregulationsbycommunitypharmaciesadescriptiveobservationalstudy
AT favourogonnanwani pentazocinemisuseamongsicklecelldiseasepatientsandtheroleoflackofenforcementofopioiddispensingregulationsbycommunitypharmaciesadescriptiveobservationalstudy
AT oghenevwogagaobukohwoedenya pentazocinemisuseamongsicklecelldiseasepatientsandtheroleoflackofenforcementofopioiddispensingregulationsbycommunitypharmaciesadescriptiveobservationalstudy